OTC Markets OTCQB - Delayed Quote USD
ZIVO Bioscience, Inc. (ZIVO)
16.00
+3.50
+(28.00%)
At close: April 23 at 2:50:04 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
157.22
157.22
27.65
--
--
Cost of Revenue
108.27
108.27
16.04
--
--
Gross Profit
48.95
48.95
11.61
--
--
Operating Expense
13,410.85
13,410.85
7,274.62
8,731.97
8,645.12
Operating Income
-13,361.90
-13,361.90
-7,263.01
-8,731.97
-8,645.12
Net Non Operating Interest Income Expense
-22.94
-22.94
-514.17
-13.32
-233.28
Other Income Expense
--
--
--
--
122.52
Pretax Income
-13,384.84
-13,384.84
-7,777.18
-8,745.29
-8,755.88
Net Income Common Stockholders
-13,384.84
-13,384.84
-7,777.18
-8,745.29
-8,755.88
Diluted NI Available to Com Stockholders
-13,384.84
-13,384.84
-7,777.18
-8,745.29
-8,755.88
Basic EPS
-4.83
-4.23
-4.60
-5.57
-6.90
Diluted EPS
-4.83
-4.23
-4.60
-5.57
-6.90
Basic Average Shares
2,762.96
3,167.15
1,690.01
1,569.94
1,271.51
Diluted Average Shares
2,762.96
3,167.15
1,690.01
1,569.94
1,271.51
Total Operating Income as Reported
-13,361.90
-13,361.90
-7,263.01
-8,731.97
-8,645.12
Total Expenses
13,519.12
13,519.12
7,290.66
8,731.97
8,645.12
Net Income from Continuing & Discontinued Operation
-13,384.84
-13,384.84
-7,777.18
-8,745.29
-8,755.88
Normalized Income
-13,384.84
-13,384.84
-7,777.18
-8,745.29
-8,878.40
Interest Expense
22.94
22.94
514.17
13.32
233.28
Net Interest Income
-22.94
-22.94
-514.17
-13.32
-233.28
EBIT
-13,361.90
-13,361.90
-7,263.01
-8,731.97
-8,522.60
EBITDA
-13,361.90
-13,361.90
-7,263.01
-8,731.97
-8,522.60
Reconciled Cost of Revenue
108.27
108.27
16.04
--
--
Net Income from Continuing Operation Net Minority Interest
-13,384.84
-13,384.84
-7,777.18
-8,745.29
-8,755.88
Total Unusual Items Excluding Goodwill
0.82
--
--
--
122.52
Total Unusual Items
0.82
--
--
--
122.52
Normalized EBITDA
-13,361.90
-13,361.90
-7,263.01
-8,731.97
-8,645.12
12/31/2021 - 12/15/2003
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CLDWW Calidi Biotherapeutics, Inc.
0.0055
-15.38%
CINGW Cingulate Inc.
0.0370
+11.78%
EVLO Evelo Biosciences, Inc.
0.0005
0.00%
CNBX CNBX Pharmaceuticals Inc.
0.0039
-4.88%
MNOV MediciNova, Inc.
1.4900
+0.68%
LIXT Lixte Biotechnology Holdings, Inc.
1.3000
+15.04%
AAGH America Great Health
0.0050
0.00%
SLRX Salarius Pharmaceuticals, Inc.
0.7190
+9.10%
ATHE Alterity Therapeutics Limited
3.5100
+1.15%
VTVT vTv Therapeutics Inc.
20.55
+3.32%